In the blood
Marking the International Thalassemia Day today, Dr Esha Kaul tells you why 3.4 per cent of the Indian population suffers from thalassaemia, suggests prevention measures and the best way to treat this complex affliction
There are more than 10,000 thalassemic children born every year in India. Statistically about 3.4 per cent of Indian population suffers from thalassemia. Thalassemia is an inherited blood disorder in which a person suffers from anemia as a result of decreased production as well as rapid destruction of the red blood cells (RBCs).
According to hematology experts, this condition can largely be prevented with increased awareness. Here is all you need to know about the condition.
Overall, there are two kinds of thalassemia— alpha and beta. Alpha thalassemia is seen more in people of Chinese and African origin whereas beta-thalassemia is largely seen in India.
Depending on the inherited pattern, the condition can present in two major forms:
Thalassemia minor: In case the defective gene is inherited from either of the parents the child will be thalassemia minor.
Thalassemia major: If the defective gene is inherited from both the parents then the child will be thalassemia major, a severe form of thalassemia.
Thalassemia is a genetic condition. There are specific genes that code for hemoglobin, the protein in RBCs responsible for carrying oxygen throughout the body. There are separate genes coding for alpha and beta chains that are self-arranged to form a hemoglobin molecule. Defects in either of the genes can result in the production of abnormal hemoglobin which causes RBC destruction.
You may inherit this defective gene either from your mother or your father or from both.
Thalassemia minor: Those who have inherited the defective gene for alpha chain of hemoglobin usually don’t show any symptoms. That’s because the alpha gene defect doesn’t cause any major problem that interferes with the hemoglobin function.
But people who have a defective beta chain of hemoglobin have mild anemia. These people are usually healthy fully functional with a normal lifespan. There haemoglobin can range from completely normal to 1-2 gm/dL less than normal. The only way to know that someone is thalassemia minor is by a blood test.
Thalassemia major: People who have inherited the defect for beta chain of hemoglobin from both the parents suffer from thalassemia major, also called hemoglobin H disease or Cooley’s anemia. The symptoms are severe and usually seen within the first two years of life. They include severe anemia, a pale and listless appearance, loss of appetite, delayed growth and puberty, jaundice, enlargement of the spleen, liver and heart and weak bones.
Severe thalassemia is diagnosed early in childhood because the signs develop within the first two years of life. Milder form of thalassemia is diagnosed with a complete blood count and hemoglobin test.
- A complete blood count (CBC) can raise suspicion of thalassemia.
- A microscopic analysis helps identify abnormal RBCs that appear smaller in size
- A test called hemoglobin electrophoresis is used to confirm the diagnosis and to identify whether the patient has alpha or beta thalassemia
- Mutational analysis can be done when results of hemoglobin electrophoresis are inconclusive
Treatment depends on the form of condition the patient suffers from. Currently, it is treated with:
Blood transfusion: It is the main treatment given to patients with major thalassemia. Transfusion is required every two-three weeks to supplement RBCs and maintain a haemoglobin level of around 9gm/dL
Iron chelation therapy: With repeated blood transfusions, the iron load of the body in thalassemic patients increases. This condition is called iron overload which can create complications and damage other healthy organs including the heart and liver. To prevent iron overload, medicines are prescribed. Deferoxamine and Deferasirox are common iron-chelators that bind free iron in the blood and cause its elimination through urine.
Supplements: Folic acid supplements must be given to enhance the production of healthy RBCs.
For the advance treatment, stem cell or bone marrow transplant is the only curative option for thalassemia major. Stem cells are the precursors of RBCs present in the bone marrow. In thalassemic patients, the stem cells themselves carry the defect causing production of abnormal RBCs. But when bone marrow cells from a healthy donor are transplanted into the patient to replace those faulty stem cells they can make their own healthy RBCs.
This treatment has been carried out successfully for thousands of children with thalassemia in India and worldwide. The best potential donor is a brother or sister. A special genetic test called HLA is done to identify genetic match. There is a possibility of any one sibling of being a complete match. Other means of finding a match is by voluntary donor registries. Most recently a technique called haploidentocal or half match transplant has been developed. This allows parents to be potential donors as well offering this curative therapy to more and more children.
Another approach to cure thalassemia involves insertion of normal gene in stem cells of the bone marrow of the patients. With the normal gene, the bone marrow cells will be able to produce their own healthy red blood cells with normal hemoglobin.
Since thalassemia is a genetic condition, it can be prevented only in future generations. People who are living with mild thalassemia can prevent their children from carrying the defect with the help of genetic screening. In fact, such individuals should definitely have their partners screened before getting married. Read more about causes, symptoms, diagnosis and treatment of anemia.
All the responsible stakeholders, Government bodies, private players, medical communities, media should create awareness around the disease through different activities like seminars, symposium, publications etc.
Genetic counselling needs to be given to thalassemia carriers and parents who have a thalassemic child. It’s important to provide people at risk with full information which is counselled and is not-directive in nature.
The writer is consultant, Hemato Oncology and BMT, Jaypee Hospital, Noida
- the good loser 22 May 2018 | Dr Naresh Arora
- fasting the healthy way 22 May 2018 | Saumya Satakshi
- TIPTOP 22 May 2018 | Pioneer Health
- Docyard | Thyroid is a major disruptor 22 May 2018 | Dr Dhrity Vats
- SummerCooler 22 May 2018 | Pioneer Health
- DadiKaKehna 22 May 2018 | Roshani Devi
- ‚ÄėHealthcare should be part of school syllabus‚Äô 22 May 2018 | PNS
- a b c d OF DYSLEXIA 15 May 2018 | Dr Sapna Zarwal
- Docyard | New scans for tumours 15 May 2018 | Dr Vikram Lele
- Family time healthy time 15 May 2018 | PNS
Sunday EditionView All
20 May 2018 | PNS
New Delhi: “Now, let us enjoy our holidays,” this is how the Supreme Court concluded the hearing on the Karnataka power row on Saturday. The courtroom burst into a bout of laughter as Justice AK Sikri, who headed the three-judge Bench, made the jovial remark ...
STATE EDITIONSView All
22 May 2018 | Staff Reporter | Bhopal
A women’s youth camp under Go Rurban camp with the objective to connect rural and urban youth together will be held at village Sijora district Dindori. The basic idea of the camp is to build a stronger bridge in order to fill the gap between rural and urban society...